๐Ÿ›๏ธ Verified NIH Record โ€ข Updated 2024-09-09

Antibiotics for Delirium in Older Adults With No Clear Urinary Tract Infection (NCT06004739)

๐ŸŸข Recruiting Observational / Diagnostic ๐Ÿ’Š Investigational Drug / Biologic Sponsor: Mount Sinai Hospital, Canada

๐Ÿฉบ Plain-English Summary (8th-Grade Level)

Delirium is an acute confusional state that is experienced by many older adults who are admitted to hospital. To treat delirium the underlying cause needs to be identified promptly, but this is challenging. One of the potential causes of delirium is infection. Urine tests show that most patients experiencing delirium have bacteria in their urine, however, bacteria in the urine is common among older adults, and does not automatically indicate an infection is present. As a result it is difficult to know whether a lower urinary tract infection is present as individuals with delirium are frequently unable to report clinical signs of infection - symptoms of pain or discomfort with urination, having to urinate more frequently or pelvic discomfort. Very often, individuals with delirium are treated with antibiotics despite the fact that it is unknown whether antibiotics help to improve delirium in cases where bacteria in the urine is present. This proposed study is a randomized controlled trial that will examine if adults (age 60 or older) with delirium and suspected infection benefit from taking antibiotics.

Who can join: Review the eligibility criteria below.

Location: Northwestern Memorial Hospital โ€” Chicago, Illinois

Age range: 60 Years

๐Ÿ“‹ "Do I Qualify?" โ€” 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria โ†—

๐Ÿ“ All Participating Trial Locations (7 Sites)

  • Northwestern Memorial Hospital โ€” Chicago, Illinois
  • The Ottawa Hospital Civic Campus โ€” Ottawa,
  • The Ottawa Hospital General Campus โ€” Ottawa,
  • Hennick Bridgepoint Hospital โ€” Toronto,
  • Michael Garron Hospital โ€” Toronto,
  • Mount Sinai Hospital โ€” Toronto,
  • Toronto General Hospital โ€” Toronto,

๐Ÿ“ž Contact the Study Coordinator

Phone: (416) 586-4800

Email: mike.fralick@mail.utoronto.ca

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

๐Ÿ’ฐ Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Infectious Disease

๐Ÿ’ก How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Contact the study coordinator using the phone/email above.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
๐Ÿ›๏ธ View Official NIH Record โ†—